Abstract
Novel palliative anticancer therapies, including targeted agents, cause dermatologic toxicities that impact patients' functional status and quality of life. As the frequency in utilization of targeted agents in palliative and hospice care settings increases, so does the need for nurses to maintain knowledge and expertise on the management of treatment-induced dermatologic toxicities. The purpose of this review was to describe cancer treatment-related dermatologic toxicities through a case presentation and describe strategies for prevention, assessment, and management of the symptoms in palliative care settings. Vigilance in assessment, prevention, and management of symptomatic dermatologic toxicities is critical to improving patient care. Palliative care nurses can improve patient care through counseling, education, and support. Early identification of symptomatic dermatologic toxicities can facilitate treatment in a timely fashion. Palliative care nurses can play an integral role in symptom management related to dermatologic toxicities for cancer patients receiving targeted therapies.